It appears JavaScript is disabled. In order for this website to function correctly you need to enable JavaScript in your browser.

Back to safety notices

PRAC meeting highlights 10-13 March 2025

14/03/2025

Medicines for human use Pharmacovigilance risk assessment committee (PRAC)

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the March 2025 meeting are now available on the EMA website.